23andMe to Be Bought by Regeneron Pharmaceuticals, a Biotech Company, for $256 Million

Regeneron Pharmaceuticals said it would acquire 23andMe, which filed for bankruptcy in March and would continue to offer consumer DNA testing services…

Regeneron Pharmaceuticals said it would acquire 23andMe, which filed for bankruptcy in March and would continue to offer consumer DNA testing services…
Read More

About Author

Michael Levenson

See author's posts

23andMe to Be Bought by Regeneron Pharmaceuticals, a Biotech Company, for $256 Million

About Author

Michael Levenson

Microsoft just launched an AI that discovered a new chemical in 200 hours instead of years

23andMe and its user data will soon belong to a pharmaceutical giant

Biotechnology Company Regeneron to Buy 23andMe for $256 million

FDA outlines stricter Covid vaccine booster approval standards for healthy people

This Workout Plan Uses Science to Build Next-Level Core Strength

Fall Covid vaccine rollout for healthy kids, adults is likely not going to happen – NBC News

I Let ChatGPT Plan My Meals for Two Weeks

Mitochondrial protein may improve selective liver cancer treatment

Brian Tyree Henry Is, Finally, Exactly Who He Wants to Be

The True Story Behind The Alto Knights, and the Feud Between Frank Costello and Vito Genovese

Vitamin A Is Good For You…Until It’s Not

The 15 Best Protein Bars, Approved By Dietitians and Editor Tested

Vutrisiran Snags FDA Approval for TTR Amyloidosis Cardiomyopathy

FDA outlines stricter Covid vaccine booster approval standards for healthy people

This Workout Plan Uses Science to Build Next-Level Core Strength

Fall Covid vaccine rollout for healthy kids, adults is likely not going to happen – NBC News

I Let ChatGPT Plan My Meals for Two Weeks

Mitochondrial protein may improve selective liver cancer treatment

About PhaMed

Recent News

About Author

More Stories

You may have missed

About PhaMed

Recent News

Categories